In a recent article published by La Vanguardia, one of Spain’s leading national newspapers, we shared insights into our role in managing complex international biomedical research collaborations. Featuring perspectives from ourCEO Carlos Díaz and our COO Sandra Pla, the article highlights how SYNAPSE combines scientific expertise, strategic management and multidisciplinary coordination to help transform research collaborations into tangible results with a meaningful impact on society.
Today's biomedical challenges increasingly require collaboration between universities, hospitals, research institutions, pharmaceutical companies, regulatory bodies and patient organisations. While bringing together diverse expertise is essential for scientific progress, coordinating organisations with different priorities and ways of working presents significant challenges.
SYNAPSE addresses these challenges by providing strategic and operational management for large international consortia and public-private partnerships, helping partners align their objectives and work effectively towards shared goals.
"Everyone understands the need to collaborate to address today's major research challenges. However, structuring that collaboration so that radically different institutions and individuals can come together around a common project is a real challenge." - Carlos Díaz (CEO)
SYNAPSE's role extends far beyond traditional project administration. Its multidisciplinary team combines scientific expertise with project management, finance, legal affairs, communication and strategic planning to support research initiatives throughout their lifecycle, from initial design to the exploitation of results.
By coordinating stakeholders, facilitating decision-making and anticipating challenges, SYNAPSE enables researchers to focus on science while ensuring projects progress efficiently. The company also acts as an honest broker, providing neutral coordination between academic and industry partners.
"Our projects vary in scale, but we are typically talking about tens of millions of euros per project, involving between fifteen and thirty institutions of all kinds. Over the years, we have probably managed more than €500 million." - Sandra Pla (COO)
SYNAPSE has built its international reputation through a specialised approach focused on selected, high-impact biomedical research initiatives, working alongside leading researchers and organisations across Europe and beyond.
"Our strategy has always been to specialise. We are not funding brokers, nor do we aim to manage as many projects as possible. Our priority is to work side by side with leading researchers on selected projects, supporting every stage from initial design through to the subsequent exploitation of results. This approach has earned us a leading position at European level." - Carlos Díaz (CEO)
This expertise is reflected in SYNAPSE's involvement in projects addressing major biomedical challenges, including Alzheimer's disease, tuberculosis, alternatives to animal testing and the use of large-scale clinical data to improve medicine safety and effectiveness.
Ultimately, as highlighted in La Vanguardia, effective research management is a key enabler of scientific progress, helping translate collaboration and research investment into meaningful benefits for society.